Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-03

Clinical Trial Update: Denervation of the renAl sympathetIc nerveS in hearT Failure With nOrmal Lv Ejection Fraction [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial investigating denervation of the renal sympathetic nerves in heart failure with normal ejection fraction was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: UMC Utrecht | Conditions: Diastolic Heart Failure, Hypertension | Phase 2, Phase 3 | Status: TERMINATED